James E. Foley

Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited

U. Hassiepen, J. Foley, J. Trappe, 2008, Diabetes, obesity & metabolism.

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

S. Dejager, J. Foley, M. Evans, 2015, Diabetes Therapy.